FDA Guides Limits on Farm Animal Antibiotic Durations
Published Date: 2/13/2026
Notice
Summary
The FDA is rolling out new guidance to help drug makers set clear time limits for using important antibiotics in animals raised for food. This change aims to slow down antibiotic resistance, keeping these medicines effective for people. Drug companies can choose to update their approvals over time, with no immediate costs or deadlines forced on them.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Drug Makers Can Voluntarily Set Use Limits
If you make animal antibiotics, FDA's final guidance (published February 13, 2026) recommends you may voluntarily establish defined durations of use in approved new animal drug applications and abbreviated applications. FDA also proposes timelines for sponsors to align affected applications, but the Agency did not impose immediate deadlines or require immediate costs.
Guidance to Slow Antibiotic Resistance
On February 13, 2026, FDA issued final guidance recommending that drug sponsors define time limits for medically important antibiotics fed to food-producing animals to help slow antimicrobial resistance and keep these medicines effective for people. The guidance is voluntary and describes how sponsors may add defined durations into their approved animal drug applications.
Guidance Seeks Typical Durations To Guide Vets
FDA revised the final guidance to ask sponsors to propose and justify a typical duration range as well as a maximum permitted duration so the labeled durations reflect what veterinarians would authorize in most circumstances. The change responds to concerns that veterinarians might default to the maximum labeled duration if only a maximum is provided.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10321 — Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) Manufactured by Moderna TX Inc.
The FDA is holding a public meeting on June 18, 2026, to talk about the safety and effectiveness of MFLUSIVA, a new flu vaccine made by Moderna. Anyone can watch online and share their thoughts before June 17. This is a big deal for people who get flu shots and could affect how this vaccine is used and approved.
2026-10295 — M11 Clinical Electronic Structured Harmonised Protocol (CeSHarP); International Council for Harmonisation; Guidance for Industry; Availability
The FDA just released a new, easy-to-use digital guide called M11 CeSHarP to help everyone involved in clinical trials share and review study plans faster and clearer. This affects drug companies, researchers, and regulators worldwide by setting a global standard for how trial info is written and shared electronically. The new rules kick in now, aiming to save time and reduce confusion, with no direct cost but big efficiency gains.
2026-10277 — Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
The FDA just released new draft guides to help drug makers design studies proving their generic drugs work like the originals. If you’re in the drug business, now’s your chance to share feedback by July 21, 2026, before these guides become final. These updates aim to speed up drug approvals, potentially saving time and money for companies and patients alike!
2026-10284 — Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability
The FDA just released new guidance to help baby formula makers prove their products have good-quality protein using special rat studies. This update affects formula manufacturers and labs, making it easier and clearer to show their formulas meet nutrition standards. The guidance is effective now, helping companies avoid costly mistakes and speed up getting new formulas to market.
2026-10268 — Notice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
The FDA decided not to add Hepatitis Delta Virus (HDV) to the list of tropical diseases because it doesn’t fully meet the rules about market size and who it affects. This means drug makers won’t get special priority review vouchers for HDV treatments right now. People working on HDV drugs should keep an eye out for future updates but won’t see changes or new incentives immediately.
2026-10190 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
The FDA is updating how companies ask for extra patent time when their new drugs or devices take a while to get approved. This affects drug and medical device makers who want to protect their inventions longer. Comments on these changes are open until June 22, 2026, and the update aims to keep the process clear without adding extra costs or delays.
Previous / Next Documents
Previous: 2026-02932 — Foreign-Trade Zone (FTZ) 38, Notification of Proposed Production Activity; Coroplast Tape Corporation; (Pressure Sensitive Tapes); Rock Hill, South Carolina
Coroplast Tape Corporation wants to start making various types of pressure-sensitive tapes at their Rock Hill, South Carolina facility inside Foreign-Trade Zone 38. This move lets them use certain imported materials with lower or no import taxes, saving money and speeding up production. The government is reviewing this plan, which could kick off soon and help Coroplast stay competitive in the tape business.
Next: 2026-02937 — Depository Library Council Meeting
The Depository Library Council is holding a free, online meeting on March 4-5, 2026, to talk about important updates for libraries that share government info with the public. Anyone interested can join, and closed captions will be available. This meeting helps keep libraries in the loop and ready to serve their communities better—no cost or travel needed!